Seguir
Edward Kong
Edward Kong
Harvard University Department of Economics and Harvard Medical School
Dirección de correo verificada de fas.harvard.edu
Título
Citado por
Citado por
Año
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals
JJ Lee, R Wedow, A Okbay, E Kong, O Maghzian, M Zacher, ...
Nature genetics 50 (8), 1112-1121, 2018
2134*2018
Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences
R Karlsson Linnér, P Biroli, E Kong, SFW Meddens, R Wedow, ...
Nature genetics 51 (2), 245-257, 2019
6252019
Disentangling policy effects using proxy data: Which shutdown policies affected unemployment during the COVID-19 pandemic?
E Kong, D Prinz
Journal of Public Economics 189, 104257, 2020
244*2020
PROMIS computer adaptive tests compared with time to brake in patients with complex lower extremity trauma
CY Kim, DH Wiznia, L Averbukh, A Torres, E Kong, S Kim, MP Leslie
Journal of orthopaedic trauma 30 (11), 592-596, 2016
142016
Adverse selection and (un) natural monopoly in insurance markets
E Kong, TJ Layton, M Shepard
Working paper, Harvard Uni& versity, 2023
10*2023
How do copayment coupons affect branded drug prices and quantities purchased?
L Dafny, K Ho, E Kong
National Bureau of Economic Research, 2022
102022
Do physician incentives increase patient medication adherence?
E Kong, J Beshears, D Laibson, B Madrian, K Volpp, G Loewenstein, ...
Health Services Research 55 (4), 503-511, 2020
82020
US hospital characteristics associated with price transparency regulation compliance
Y Ji, E Kong
JAMA Health Forum 3 (6), e221702-e221702, 2022
72022
Provision of hospital price information after increases in financial penalties for failure to comply with a US federal Hospital Price Transparency Rule
E Kong, Y Ji
JAMA Network Open 6 (6), e2320694-e2320694, 2023
42023
Turnover in zero-premium status among health insurance marketplace plans available to low-income enrollees
E Kong, M Shepard, A McIntyre
JAMA Health Forum 3 (4), e220674-e220674, 2022
32022
Estimating competitive effects in firm entry with applications in the generic pharmaceutical industry
E Kong
Yale University Department of Economics 3, 2016
32016
Characterizing the Reaction of Doctors to COVID-19 on Twitter
K Hsia, E Kong
Journal of quantitative description: digital media 2, 2022
22022
A repository of polygenic scores
A Okbay, D Benjamin, C Burik, D Cesarini, E Kong, O Maghzian, P Turley
BEHAVIOR GENETICS 48 (6), 503-503, 2018
2018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–13